Literature DB >> 2729230

In situ distribution of enolase isozymes in chronic liver disease.

Y Fukuda1, Y Miyazawa, M Imoto, Y Koyama, I Nakano, H Nagura, K Kato.   

Abstract

Liver biopsy specimens with or without chronic liver diseases were examined immunohistochemically to determine the distribution of enolase isozymes (alpha, beta, and gamma). In normal liver, alpha-enolase was positively stained in almost all hepatocytes and bile duct cells. beta- and gamma-enolases were localized in hepatocytes and bile duct cells, respectively. Electron microscopic studies revealed that Kupffer cells and sinusoidal endothelial cells had both alpha- and gamma-enolases. In chronic active hepatitis and cirrhosis, proliferated biliary ductular cells had both alpha- and gamma-enolases, but did not express beta-enolase. This is almost the same localization pattern of enolase isozymes as in preexisting bile duct cells. gamma-Enolase was detected in some hepatocytes in eight of 12 cases with chronic active hepatitis and six of 12 cases with cirrhosis. These hepatocytes were small, showed a cobblestone pattern, and binucleate cells were frequent. On the other hand, rosette-formed hepatocytes adjacent to a regenerating bulging lobule were not stained for gamma-enolase. These results suggest that regenerating hepatocytes have gamma-enolase and that, with maturation, hepatocytes lose it.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729230

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

2.  α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia.

Authors:  Brandy R Lu; Stephen M Brindley; Rebecca M Tucker; Cherie L Lambert; Cara L Mack
Journal:  Gastroenterology       Date:  2010-07-23       Impact factor: 22.682

3.  Neuroendocrine features of reactive bile ductules in cholestatic liver disease.

Authors:  T Roskams; J J van den Oord; R De Vos; V J Desmet
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  N Durany; J Joseph; E Campo; R Molina; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.